These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 36884274)

  • 61. Recovery of health-related quality of life in patients undergoing robot-assisted radical cystectomy with intracorporeal diversion.
    Abozaid M; Tan WS; Khetrapal P; Baker H; Duncan J; Sridhar A; Briggs T; Selim M; Abdallah MM; Elmahdy AA; Elserafy F; Kelly JD
    BJU Int; 2022 Jan; 129(1):72-79. PubMed ID: 34092021
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Chronic radiation-induced rectal injury after adjuvant radiotherapy for pelvic malignant tumors: report based on a phase 3 randomized clinical trial].
    Zhou Y; Huang H; Wan T; Feng YL; Liu JH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):962-968. PubMed ID: 34823296
    [No Abstract]   [Full Text] [Related]  

  • 63. Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.
    Heutte N; Flechtner HH; Mounier N; Mellink WA; Meerwaldt JH; Eghbali H; van't Veer MB; Noordijk EM; Kluin-Nelemans JC; Lampka E; Thomas J; Lugtenburg PJ; Viterbo L; Carde P; Hagenbeek A; van der Maazen RW; Smit WG; Brice P; van Marwijk Kooy M; Baars JW; Poortmans P; Tirelli U; Leeksma OC; Tomsic R; Feugier P; Salles G; Gabarre J; Kersten MJ; Van Den Neste E; Creemers GJ; Gaillard I; Meijnders P; Tertian G; Reman O; Muller HP; Troncy J; Blanc M; Schroyens W; Voogt PJ; Wijermans P; Rieux C; Fermé C; Henry-Amar M;
    Lancet Oncol; 2009 Dec; 10(12):1160-70. PubMed ID: 19828373
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Japanese version of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE): psychometric validation and discordance between clinician and patient assessments of adverse events.
    Kawaguchi T; Azuma K; Sano M; Kim S; Kawahara Y; Sano Y; Shimodaira T; Ishibashi K; Miyaji T; Basch E; Yamaguchi T
    J Patient Rep Outcomes; 2017; 2(1):2. PubMed ID: 29757309
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The EORTC Quality of Life Questionnaire for cancer patients (QLQ-C30): Australian general population reference values.
    Mercieca-Bebber R; Costa DS; Norman R; Janda M; Smith DP; Grimison P; Gamper EM; King MT
    Med J Aust; 2019 Jun; 210(11):499-506. PubMed ID: 31155722
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of general symptom level, specific adverse events, treatment patterns, and patient characteristics on health-related quality of life in patients with multiple myeloma: results of a European, multicenter cohort study.
    Jordan K; Proskorovsky I; Lewis P; Ishak J; Payne K; Lordan N; Kyriakou C; Williams CD; Peters S; Davies FE
    Support Care Cancer; 2014 Feb; 22(2):417-26. PubMed ID: 24122403
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10).
    Marschner N; Wilke J; Reschke D; Kaiser F; Schmoor C; Grugel R; Boller E
    J Med Econ; 2018 Sep; 21(9):920-929. PubMed ID: 29874105
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation study.
    Machingura A; Taye M; Musoro J; Ringash J; Pe M; Coens C; Martinelli F; Tu D; Basch E; Brandberg Y; Grønvold M; Eggermont A; Cardoso F; Van Meerbeeck J; van der Graaf WTA; Taphoorn M; Reijneveld JC; Soffietti R; Sloan J; Velikova G; Flechtner H; Bottomley A;
    Eur J Cancer; 2022 Jul; 170():1-9. PubMed ID: 35569438
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cardiopulmonary-related patient-reported outcomes in a randomized clinical trial of radiation therapy for breast cancer.
    Van Parijs H; Vinh-Hung V; Fontaine C; Storme G; Verschraegen C; Nguyen DM; Adriaenssens N; Nguyen NP; Gorobets O; De Ridder M
    BMC Cancer; 2021 Nov; 21(1):1177. PubMed ID: 34736429
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Assessing quality of life during chemotherapy for pleural mesothelioma: feasibility, validity, and results of using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and Lung Cancer Module.
    Nowak AK; Stockler MR; Byrne MJ
    J Clin Oncol; 2004 Aug; 22(15):3172-80. PubMed ID: 15284270
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identifying Patients Whose Symptoms Are Underrecognized During Treatment With Breast Radiotherapy.
    Jagsi R; Griffith KA; Vicini F; Boike T; Dominello M; Gustafson G; Hayman JA; Moran JM; Radawski JD; Walker E; Pierce L;
    JAMA Oncol; 2022 Jun; 8(6):887-894. PubMed ID: 35446337
    [TBL] [Abstract][Full Text] [Related]  

  • 72. PRO-CTCAE reveals under-recognition of dermatologic symptom burden in hospitalized cancer patients.
    Gu S; Menzer C; Hay JL; Pena C; Dusza S; Lacouture ME; Markova A
    Support Care Cancer; 2023 May; 31(6):337. PubMed ID: 37183206
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cognitive Interview-Based Validation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in Adolescents with Cancer.
    Reeve BB; McFatrich M; Pinheiro LC; Freyer DR; Basch EM; Baker JN; Withycombe JS; Sung L; Mack JW; Waldron MK; Mowbray C; Palma D; Hinds PS
    J Pain Symptom Manage; 2017 Apr; 53(4):759-766. PubMed ID: 28062347
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer.
    Schwartzberg L; McIntyre K; Wilks S; Puhalla S; O'Shaughnessy J; Berrak E; He Y; Vahdat L
    BMC Cancer; 2019 Jun; 19(1):578. PubMed ID: 31195996
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Health-related quality of life: Impact of surgery and treatment modality in breast cancer.
    Enien MA; Ibrahim N; Makar W; Darwish D; Gaber M
    J Cancer Res Ther; 2018; 14(5):957-963. PubMed ID: 30197331
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Psychometric properties and measurement equivalence of the Multidimensional Fatigue Syndrome Inventory- Short Form (MFSI-SF) amongst breast cancer and lymphoma patients in Singapore.
    Chan A; Lew C; Wang XJ; Ng T; Chae JW; Yeo HL; Shwe M; Gan YX
    Health Qual Life Outcomes; 2018 Jan; 16(1):20. PubMed ID: 29351803
    [TBL] [Abstract][Full Text] [Related]  

  • 77. PRO-ONKO-selection of patient-reported outcome assessments for the clinical use in cancer patients-a mixed-method multicenter cross-sectional exploratory study.
    Schmidt H; Merkel D; Koehler M; Flechtner HH; Sigle J; Klinge B; Jordan K; Vordermark D; Landenberger M; Jahn P
    Support Care Cancer; 2016 Jun; 24(6):2503-12. PubMed ID: 26676238
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Feasibility and acceptability of electronic symptom surveillance with clinician feedback using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE) in Danish prostate cancer patients.
    Baeksted C; Pappot H; Nissen A; Hjollund NH; Mitchell SA; Basch E; Bidstrup PE; Dalton SO; Johansen C
    J Patient Rep Outcomes; 2017; 1(1):1. PubMed ID: 29757324
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prospective analysis of patient-reported outcomes and physician-reported outcomes with gynecologic cancer chemotherapy.
    Takenaga T; Kuji S; Tanabe KI; Kanamori R; Imai H; Takeuchi J; Kondo H; Ohara T; Iwatani T; Suzuki N
    J Obstet Gynaecol Res; 2024 Jan; 50(1):75-85. PubMed ID: 37852304
    [TBL] [Abstract][Full Text] [Related]  

  • 80. EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1,036 individuals.
    Pilz MJ; Gamper EM; Efficace F; Arraras JI; Nolte S; Liegl G; Rose M; Giesinger JM;
    BMC Public Health; 2022 May; 22(1):1040. PubMed ID: 35610611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.